Clinical Trial

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis (MONARCH)
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2023-10-27; most recent amendment 2026-05-05.
Status change: Recruiting → Active, Not Recruiting 2025-08-13
Status change: Not Yet Recruiting → Recruiting 2023-11-01
Trial Details
NCT Number NCT06108219
Lead Sponsor Corcept Therapeutics
Conditions Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH)
Enrollment 175 participants
Start Date 2023-10-25
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-08